ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1626

Unique Biological Profile of Germinal Centres Within Tertiary Lymphoid Structures in the Salivary Glands of Patients with Sjögren’s Syndrome

SABA NAYAR1, Jason D. turner1, Saba Asam1, Serena Colfrancesco2, Onorina Berardicurti3, Valentina Iannizzotto1, Charlotte G Smith1, Joe Flint1, Ana Teodósio1, David H Gardner1, Professor Simon Bowman4, Wan-Fai Ng5, Adam Croft1, Andrew Filer1, Benjamin A. Fisher1, Christopher Buckley6 and Francesca Barone7, 1University of Birmingham, Birmingham, United Kingdom, 2University of Rome, Rome, Italy, 3Rheumatology Unit, Pescara Hospital, Pescara, Italy, 4University Hospitals Birmingham, Birmingham, United Kingdom, 5Newcastle University, Newcastle, United Kingdom, 6University of Oxford, Oxford, United Kingdom, 7University of Birmingham, Needham, MA

Meeting: ACR Convergence 2022

Keywords: Sjögren's syndrome

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 13, 2022

Title: Abstracts: Sjögren's Syndrome – Basic and Clinical Science

Session Type: Abstract Session

Session Time: 5:00PM-6:00PM

Background/Purpose: Tertiary lymphoid structures (TLS) are accumulations of lymphoid cells that share similar cellular compartments, organization and function when compared to secondary lymphoid organs (SLOs) such as tonsil. TLS germinal centres (GC) provide a local hub for maturation and proliferation of auto-reactive B-cells and expansion of malignant B-cell clones. TLS that form within salivary glands (SGs) of Sjögren’s syndrome (SjS) patients are clearly associated with poor disease outcome, autoantibody production and lymphoma development. The phenotypical and functional features supporting TLS pathogenic properties are largely unclear.

Methods: Frozen SGs were obtained from SjS patients and selected for presence of germinal centre (GC)+ TLS. SG and tonsil were stained, microdissected. Isolated RNA from SG TLS and tonsil GC were used for RNAseq using ClonTech SMARTseq v4 kit. Nanostring GeoMx Digital Spatial Profiler (DSP) and Multiplex IHC (Lunaphore Comet) were used for proteomic validation.

Results: Transcriptomic analysis revealed 3836 significantly differentially expressed genes in SG TLS as compared to tonsil GC. Predominant expression of the lymphoid chemokines/cytokines (CCL19, CCL21, CXCL13 and BAFF) and costimulatory molecules (CD40, ICOS, ICOSL, PD1, PDL1, PDL2) was identified in both TLS and tonsil GCs. Interestingly, CCL19, BAFF, PDL2 expression was higher in SjS TLS than tonsil GCs. Conversely, CCL21 expression was greater in tonsil GCs. Gene expression for CXCL12 was enriched in TLS GC as compared to tonsil, suggesting a potential association of this molecule with the highly inflammatory ectopic setting of TLS. Importantly, TLS GC showed significantly increased expression of STING1, IFNG and TNF along with other cytokines (IL33, IL23). Inflammatory genes encoding for the chemokines CXCL10, CXCL9 and their receptor CXCR3, were detected in TLS GC, but absent in tonsil GCs, suggesting that TLS GCs are defined by a different pro-inflammatory profile signature compared to tonsil GC. Transcriptomic and proteomic analysis of TLS GC unveiled an altered cell-proliferation/apoptosis profile with downregulation of BCL6 and AICDA, the enzymes responsible for B cell affinity maturation. Moreover, spatial proteomic analysis on Geomx and multiplex IHC revealed differences in abundance of immune cell populations. The TLS GC showed presence of GranzymeB+ CD8 T cells along with T follicular and peripheral helper cells. Furthermore, high expression of CD27, CD127, GITR and TNFSF9 was enriched in TLS GC.

Conclusion: Our study provides the first comprehensive transcriptomic and proteomic overview of the mechanisms regulating the local pathogenic microenvironment in TLS and demonstrate that these differences diverge from SLOs. We demonstrated that, although characterised by similar anatomical organization, TLS pathogenic cytokines, and cellular signature is associated with low levels of bcl6, and AID, aberrant apoptosis and costimulation, compared to GC in tonsil. Our findings unveil impaired regulation of the B cell cycle, responsible for the survival of autoreactive, poorly selected B cell clones as a key feature of SS.


Disclosures: S. NAYAR, None; J. turner, None; S. Asam, None; S. Colfrancesco, None; O. Berardicurti, None; V. Iannizzotto, None; C. Smith, None; J. Flint, None; A. Teodósio, None; D. Gardner, None; P. Bowman, Novartis, AstraZeneca, AbbVie/Abbott, Galapagos; W. Ng, None; A. Croft, None; A. Filer, None; B. Fisher, Servier, Galapagos, Janssen, Novartis, Bristol-Myers Squibb(BMS); C. Buckley, None; F. Barone, Candel Therapeutics.

To cite this abstract in AMA style:

NAYAR S, turner J, Asam S, Colfrancesco S, Berardicurti O, Iannizzotto V, Smith C, Flint J, Teodósio A, Gardner D, Bowman P, Ng W, Croft A, Filer A, Fisher B, Buckley C, Barone F. Unique Biological Profile of Germinal Centres Within Tertiary Lymphoid Structures in the Salivary Glands of Patients with Sjögren’s Syndrome [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/unique-biological-profile-of-germinal-centres-within-tertiary-lymphoid-structures-in-the-salivary-glands-of-patients-with-sjogrens-syndrome/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/unique-biological-profile-of-germinal-centres-within-tertiary-lymphoid-structures-in-the-salivary-glands-of-patients-with-sjogrens-syndrome/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology